MPT
MEDICAL PROPERTIES TRUST INC
+0.26 (+7.70%)3.65USD10.7M成交股數2.2B市值–本益比(近四季)2.2股價營收比+12.6%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 252M+13% | 270M+20% | 238M-11% | 240M-11% | 224M-283% | 226M-26% | 267M-21% | 271M-23% | −122M | 307M | 337M | 350M |
| 營業成本 | 97.3M | – | – | – | 81.4M | – | – | 40.9M | – | – | – | 182M |
| 毛利 | 155M+9% | – | – | – | 142M | – | – | 230M+37% | – | – | – | 168M |
| 毛利率 | 61.4% | – | – | – | 63.6% | – | – | 84.9% | – | – | – | 48.0% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 32.2M | 24.6M | 37.7M | 26.2M | 41.9M | 36.6M | 35.3M | 33.3M | 30.2M | 38.1M | 35.6M | 41.7M |
| 營業利益 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | 32.8M-128% | 17.4M-102% | −77.7M-76% | −98.4M-89% | −118M-82% | −801M-786% | −321M+663% | −876M-2770% | −664M | 117M | −42.0M | 32.8M |
| 淨利率 | 13.0% | 6.4% | -32.7% | -40.9% | -52.8% | -354.8% | -120.3% | -322.7% | 542.5% | 38.1% | -12.5% | 9.4% |
| 稀釋 EPS | 0.05-125% | 0.03-102% | -0.13-76% | -0.16-89% | -0.20-82% | -1.34-805% | -0.54+671% | -1.46-3020% | -1.10 | 0.19 | -0.07 | 0.05 |
| 稀釋股數 | 598M | 601M | 601M | 601M | 601M | 600M | 600M | 600M | 599M | 599M | 598M | 598M |
資產負債表 期末餘額
| 科目 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 425M | 541M | 397M | 510M | 673M | 276M | 607M | 224M | 250M | 340M | 324M | 302M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 14.8B | 15.0B | 14.9B | 15.2B | 14.9B | 15.2B | 16.2B | 17.3B | 18.3B | 19.0B | 19.2B | 19.7B |
| 有息負債 | 9.7B | 9.7B | 9.6B | 9.6B | 9.5B | 9.2B | 9.4B | 10.1B | 10.1B | 10.2B | 10.2B | 10.4B |
| 總負債 | 10.2B | 10.4B | 10.3B | 10.3B | 10.1B | 9.8B | 10.0B | 10.6B | 10.7B | 10.7B | 10.9B | 11.2B |
| 股東權益 | 4.5B | 4.6B | 4.7B | 4.8B | 4.8B | 5.4B | 6.2B | 6.7B | 7.6B | 8.3B | 8.3B | 8.4B |
| 負債比 | 69.2% | 69.3% | 68.8% | 68.1% | 67.9% | 64.3% | 61.8% | 61.2% | 58.3% | 56.4% | 56.7% | 57.0% |
| 淨現金(現金 − 有息負債) | −9.2B | −9.2B | −9.2B | −9.1B | −8.8B | −8.9B | −8.8B | −9.9B | −9.8B | −9.8B | −9.9B | −10.1B |
現金流量表 單季
| 科目 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −14.3M-3813% | – | – | – | 384K | – | – | 74.3M-45% | – | – | – | 136M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | 73.3M | 73.7M | 67.0M | 66.7M | 65.4M | 205M | 102M | 77.2M | 86.3M | 77.8M | 364M | 87.6M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 972M | -2.4% | −277M | -28.5% | -0.46 | – |
| FY2024 | 996M | +14.2% | −2.4B | -242.1% | -4.02 | – |
| FY2023 | 872M | -43.5% | −557M | -63.8% | -0.93 | – |
| FY2022 | 1.5B | -0.1% | 903M | 58.5% | 1.50 | – |
| FY2021 | 1.5B | +23.6% | 656M | 42.5% | 1.11 | – |
| FY2020 | 1.2B | +46.2% | 431M | 34.5% | 0.81 | – |
| FY2019 | 854M | +8.9% | 375M | 43.9% | 0.87 | – |
| FY2018 | 785M | – | 1.0B | 129.6% | 2.76 | – |